Product Information

TELMISARTAN 80 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1563 per EA under NDC 68462020113. Its NADAC has been published 627 times since Aug 20, 2014.

FDA first approved this application on Jul 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN 80 MG TABLET

Telmisartan
$0.1563per EA

Strength

80 mg/1

NDC

68462020113

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TELMISARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA090032

FDA Approved

7/7/2014

TE Code

AB

On Market Since

7/7/2014

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for TELMISARTAN 80 MG TABLET has been published 627 times since Aug 20, 2014, and over the history we have for it it has declined 95.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1563 per EA
All-time high$3.2916 (Sep 10, 2014)
All-time low$0.1345 (May 22, 2024)
52-week high$0.1634
52-week low$0.1473
Median price$0.3934
Average price$0.4219
Largest weekly change+53.7% (Nov 22, 2023)
Weeks tracked627
Tracking sinceAug 20, 2014

Price History

1W

+6.1%

1M

+6.1%

3M

+3.0%

6M

+2.8%

1Y

-4.4%

3Y

-35.6%

5Y

-55.0%

All

-95.3%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1563 per EA (NDC 68462020113), effective Aug 19, 2026.

How has the price of TELMISARTAN 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 95.3%. It has been tracked across 627 weekly CMS publications since Aug 20, 2014.

What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?

Since Aug 20, 2014, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.1345 (May 22, 2024) to a high of $3.2916 (Sep 10, 2014), with a median of $0.3934 per EA.

Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN 80 MG TABLET?

TELMISARTAN 80 MG TABLET (NDC 68462020113) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.